The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts

Susan L. Dalrymple, Robin E. Becker, John T. Isaacs

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences